Is Avantor a Buy as Revival Progress Faces Persistent Margin Pressure?
AVTR's Revival Program is lifting VWR growth and BMP orders, but margin pressure and soft earnings keep the recovery selective despite a higher 2026 outlook.
AVTR - Avantor, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$10.78
DETAILS
HIGH:
$14.00
LOW:
$7.00
MEDIAN:
$10.50
CONSENSUS:
$10.78
DOWNSIDE:
26.21%
Stock News
Callan Family Office LLC Invests $2.02 Million in Avantor, Inc. $AVTR
Callan Family Office LLC acquired a new position in Avantor, Inc. (NYSE: AVTR) during the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 204,134 shares of the company's stock, valued at approximately $2,021,000. Several other hedge funds and other
Advisors Capital Management LLC Invests $4.37 Million in Avantor, Inc. $AVTR
Advisors Capital Management LLC purchased a new position in shares of Avantor, Inc. (NYSE: AVTR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 441,317 shares of the company's stock, valued at approximately $4,369,000. Advisors Capital Management LLC owned about 0.07% of
Is Avantor (AVTR) Outperforming Other Medical Stocks This Year?
Here is how Avantor, Inc. (AVTR) and BrightSpring Health Services, Inc. (BTSG) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Avantor (AVTR) This Year?
Here is how Avantor, Inc. (AVTR) and Johnson & Johnson (JNJ) have performed compared to their sector so far this year.
Avantor, Inc. (AVTR) Just Flashed Golden Cross Signal: Do You Buy?
Avantor, Inc. (AVTR) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, AVTR's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
Bank of Nova Scotia Has $326,000 Stock Holdings in Avantor, Inc. $AVTR
Bank of Nova Scotia cut its stake in Avantor, Inc. (NYSE: AVTR) by 67.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 41,600 shares of the company's stock after selling 84,322 shares during the quarter. Bank of Nova
Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised
AVTR tops Q2 earnings and revenue estimates as VWR returned to organic growth early, prompting higher 2026 revenues and earnings guidance.
Avantor (NYSE:AVTR) Shares Gap Up Following Earnings Beat
Avantor, Inc. (NYSE: AVTR - Get Free Report) gapped up prior to trading on Wednesday following a stronger than expected earnings report. The stock had previously closed at $12.42, but opened at $14.49. Avantor shares last traded at $14.1420, with a volume of 7,846,527 shares trading hands. The company reported $0.21 EPS for the quarter, topping
Avantor Q2 Earnings Call Highlights
Avantor NYSE: AVTR reported second-quarter 2026 results that exceeded its expectations on several measures, supported by a return to organic growth in its VWR Distribution & Services segment, strong free cash flow and progress under its Revival operational improvement program.
Oil Spikes 7%, Nasdaq 100 Sinks Before Fed: Stock Market Today
A deepening sell-off gripped Wall Street midday Wednesday as crude oil spiked on a fresh U.S.-Iran escalation just hours before the Federal Reserve's rate verdict, dragging the S&P 500 to four-week lows and knocking the Nasdaq 100 down more than 10% from prior records.
Avantor, Inc. (AVTR) Q2 2026 Earnings Call Transcript
Avantor, Inc. (AVTR) Q2 2026 Earnings Call Transcript
Avantor (AVTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
The headline numbers for Avantor (AVTR) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Avantor, Inc. (AVTR) Beats Q2 Earnings and Revenue Estimates
Avantor, Inc. (AVTR) came out with quarterly earnings of $0.21 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.24 per share a year ago.
Avantor® Reports Second Quarter 2026 Results
Net sales of $1,692.3 million; increase of 0.5%; organic decline of 0.4% Net income of $38.1 million; Adjusted EBITDA of $254.3 million Diluted GAAP EPS of $0.06; adjusted EPS of $0.21 Operating cash flow of $178.2 million; free cash flow of $142.8 million Increases FY 2026 organic revenue growth and adjusted EPS guidance RADNOR, Pa., July 29, 2026 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, reports better than expected results for the second fiscal quarter of 2026.
Avantor, Inc. (AVTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Avantor (AVTR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AVTR vs. ICLR: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Medical Services sector have probably already heard of Avantor, Inc. (AVTR) and Icon PLC (ICLR). But which of these two stocks is more attractive to value investors?
Will Avantor (AVTR) Beat Estimates Again in Its Next Earnings Report?
Avantor (AVTR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership
AVTR's shares jump nearly 7% as NuSil expands its HIV prevention partnership for a three-month dapivirine vaginal ring.
Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product
RADNOR, Pa., July 14, 2026 /PRNewswire/ -- Avantor (NYSE: AVTR), a leading global provider of mission-critical products and services to the life sciences and advanced technology industries, announced today the expansion of a collaboration between its NuSil® brand, a premier global manufacturer of high-purity silicones suitable for use in medical devices and drug-device combination products, and the Population Council, an international nonprofit research organization, to support the development of the Council's new three-month dapivirine vaginal ring for HIV prevention.
Price Targets
Avantor price target raised to $14 from $10 at Morgan Stanley
$14.00
(was $13.66)
Morgan Stanley
Avantor price target raised to $14 from $9 at RBC Capital
$14.00
(was $13.98)
Dan Leonard
·
RBC Capital
Avantor price target raised to $13 from $11 at Deutsche Bank
$13.00
(was $14.05)
Deutsche Bank
Avantor upgraded to Hold from Underperform at Jefferies
$13.00
(was $14.38)
Jefferies
Avantor price target raised to $10.50 from $8 at Evercore ISI
$10.50
(was $10.39)
Evercore ISI
Avantor resumed with a Market Perform at Bernstein
$10.50
(was $10.08)
Bernstein
Avantor price target raised to $8 from $7 at Barclays
$8.00
(was $9.43)
UBS
Avantor assumed with Underperform from Peer Perform at Wolfe Research
$7.00
(was $9.19)
Wolfe Research
Avantor resumed with a Sector Perform at RBC Capital
$9.00
(was $7.94)
RBC Capital
Avantor price target lowered to $7 from $8.50 at Barclays
$7.00
(was $8.18)
Barclays
Avantor price target lowered to $10 from $12 at Morgan Stanley
$10.00
(was $9.38)
Morgan Stanley
Avantor price target lowered to $10.50 from $13 at UBS
$10.50
(was $9.35)
Dan Leonard
·
UBS
Avantor price target lowered to $10 from $12 at Stifel
$10.00
(was $9.24)
Stifel Nicolaus
Avantor price target lowered to $8 from $9 at Jefferies
$8.00
(was $9.24)
Tycho Peterson
·
Jefferies
Avantor price target lowered to $9 from $12 at Barclays
$9.00
(was $9.64)
Barclays
Avantor price target lowered to $11 from $15 at Baird
$11.00
(was $9.64)
Robert W. Baird
Avantor price target lowered to $10 from $12 at Evercore ISI
$10.00
(was $9.31)
Vijay Kumar
·
Evercore ISI
Avantor downgraded to In Line from Outperform at Evercore ISI
$12.00
(was $11.46)
Evercore ISI
Jefferies Downgrades Avantor Inc. (AVTR) to Underperform
$9.00
(was $11.20)
Tycho Peterson
·
Jefferies
Avantor downgraded to Equal Weight from Overweight at Barclays
$12.00
(was $11.58)
Luke Sergott
·
Barclays